UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CurvAGN: Curvature-based Adaptive Graph Neural Networks for Predicting Protein-Ligand Binding Affinity

BMC bioinformatics, 2023-10, Vol.24 (1), p.1-378, Article 378

2023

Volltextzugriff (PDF)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

Journal of hematology and oncology, 2017-03, Vol.10 (1), p.69-69, Article 69

2017

Volltextzugriff (PDF)

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

Cancer medicine (Malden, MA), 2021-02, Vol.10 (3), p.999-1011

2021

Volltextzugriff (PDF)

PB2315: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)

HemaSphere, 2023-08, Vol.7 (S3), p.e8841234-n/a

2023

Volltextzugriff (PDF)

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

Journal of hematology and oncology, 2021-01, Vol.14 (1), p.12-12, Article 12

2021

Volltextzugriff (PDF)

The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients

Clinical biochemistry, 2019-01, Vol.63, p.59-65

2019

Volltextzugriff (PDF)

The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin's lymphoma tumor growth by promoting apoptosis and autophagy

Cell communication and signaling, 2023-01, Vol.21 (1), p.16-16, Article 16

2023

Volltextzugriff (PDF)

Analysis of Capillary Water Absorption within Unsaturated Concrete Based on the Principle of Stationary Action

Buildings (Basel), 2024-10, Vol.14 (10), p.3238

2024

Volltextzugriff (PDF)

Experimental and Numerical Research on a Sand Cushion Geotechnical Seismic Isolation System in Strong Earthquakes and Cold Regions

Buildings (Basel), 2024-09, Vol.14 (9), p.2629

2024

Volltextzugriff (PDF)

Numerical Computing Research on Tunnel Structure Cracking Risk under the Influence of Multiple Factors in Urban Deep Aquifer Zones

Mathematics (Basel), 2023-08, Vol.11 (16), p.3600

2023

Volltextzugriff (PDF)

Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China

Journal for immunotherapy of cancer, 2024-05, Vol.12 (5), p.e008553

2024

Volltextzugriff (PDF)

Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

Frontiers in medicine, 2022-12, Vol.9, p.989590

2022

Volltextzugriff (PDF)

Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy

Internal Medicine, 2012, Vol.51(12), pp.1509-1515

2012

Volltextzugriff (PDF)

Detecting nontrivial products in the stable homotopy ring of spheres via the third Morava stabilizer algebra

Proceedings of the American Mathematical Society, 2024-10, Vol.152 (10), p.4521-4536

2024

Volltextzugriff (PDF)

A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

Clinical cancer research, 2019-12, Vol.25 (24), p.7363-7369

2019

Volltextzugriff (PDF)

Research on the UOSM four-port Calibration algorithm and determination method of the Transmission error term

Journal of physics. Conference series, 2024-03, Vol.2724 (1), p.12004

2024

Volltextzugriff (PDF)

Independent cover meshless particle method for complex geotechnical engineering

Frontiers of Structural and Civil Engineering, 2018-12, Vol.12 (4), p.515-526

2018

Volltextzugriff (PDF)

Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma

Cancer letters, 2022-12, Vol.551, p.215972, Article 215972

2022

Volltextzugriff (PDF)

Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up

Blood, 2023-11, Vol.142 (Supplement 1), p.6265-6265

2023

Volltextzugriff (PDF)

First Report of Phase 1 Studies of DZD8586, a BBB Penetrant LYN/BTK Dual Inhibitor, in Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)

Blood, 2023-11, Vol.142 (Supplement 1), p.4465-4465

2023

Volltextzugriff (PDF)

Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow‐up of the multicenter, single‐arm, Phase 2 study

International journal of cancer, 2022-03, Vol.150 (6), p.984-992

2022

Volltextzugriff (PDF)

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

Blood, 2022-11, Vol.140 (Supplement 1), p.10329-10331

2022

Volltextzugriff (PDF)

XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6554-6555

2022

Volltextzugriff (PDF)

Novel Chemotherapy-Free Initial Treatment of Rituximab Biosimilar Plus Pegylated Interferon α-2b in Pts with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Results of the Ripple 3-Year Follow-up Study

Blood, 2023-11, Vol.142 (Supplement 1), p.4411-4411

2023

Volltextzugriff (PDF)

A Multicenter Real-Life Study of Polatuzumab Vedotin Combined with Immunochemotherapy in Patients with R/R DLBCL: Preliminary Data on Efficacy and Safety in Chinese Cohort

Blood, 2020-11, Vol.136 (Supplement 1), p.50-51

2020

Volltextzugriff (PDF)

1 – 25 von 435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(367)
Mit Volltextzugriff
(379)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(293)
Life Sciences & Biomedicine
(159)
Technology
(108)
Humans
(83)
Physical Sciences
(72)
Materials Science
(71)
Materials Science, Multidisciplinary
(63)
Male
(52)
Female
(50)
Chemistry
(48)
Engineering
(42)
Environmental Sciences & Ecology
(41)
Environmental Sciences
(40)
Middle Aged
(30)
Adult
(27)
China
(25)
Energy & Fuels
(25)
Chemistry, Physical
(22)
Science & Technology - Other Topics
(21)
Oncology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(20)
Ssrn Electronic Journal
(16)
Environment International
(8)
Environmental Research
(8)
Chemosphere
(7)
Meeting Abstracts
(7)
Corrosion Science
(6)
Ecs Transactions
(5)
Environmental Pollution
(5)
International Journal Of Molecular Sciences
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CurvAGN: Curvature-based Adaptive Graph Neural Networks for Predicting Protein-Ligand Binding Affinity

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

PB2315: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)

Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)

The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients

The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin's lymphoma tumor growth by promoting apoptosis and autophagy

Analysis of Capillary Water Absorption within Unsaturated Concrete Based on the Principle of Stationary Action

Experimental and Numerical Research on a Sand Cushion Geotechnical Seismic Isolation System in Strong Earthquakes and Cold Regions

Numerical Computing Research on Tunnel Structure Cracking Risk under the Influence of Multiple Factors in Urban Deep Aquifer Zones

Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China

Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy

Detecting nontrivial products in the stable homotopy ring of spheres via the third Morava stabilizer algebra

A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

Research on the UOSM four-port Calibration algorithm and determination method of the Transmission error term

Independent cover meshless particle method for complex geotechnical engineering

Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma

Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up

First Report of Phase 1 Studies of DZD8586, a BBB Penetrant LYN/BTK Dual Inhibitor, in Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)

Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow‐up of the multicenter, single‐arm, Phase 2 study

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study

Novel Chemotherapy-Free Initial Treatment of Rituximab Biosimilar Plus Pegylated Interferon α-2b in Pts with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Results of the Ripple 3-Year Follow-up Study

A Multicenter Real-Life Study of Polatuzumab Vedotin Combined with Immunochemotherapy in Patients with R/R DLBCL: Preliminary Data on Efficacy and Safety in Chinese Cohort

Suchergebnisse filtern